We have tested a multiplex polymerase chain reaction (PCR) human papillomavirus (HPV) genotyping assay to fill the need for rapid and low-cost HPV detection in SubSaharan Africa. This method allows high throughput genotyping and simultaneous detection of 14 high-risk and two low-risk HPV types, by PCR amplification of HPV DNAs in a single reaction tube. In this study, we describe stepwise experiments to validate the multiplex HPV PCR assay for determination of HPV genotypes from 104 cervical brush samples from Tanzanian women. Assay performance was evaluated by determination of intra-laboratory reproducibility, sensitivity, and specificity. Overall concordance between the multiplex and line blot hybridization assays was 99% (per sample) with a κ value equal to 0.95; and 96.49% (per detection event) with a κ value of 0.92. Interobserver reproducibility of the assay per sample was 95.76% with κ of 0.91. These results demonstrate that the multiplex HPV PCR assay has high analytical sensitivity and specificity in detecting as many as 16 different HPV genotypes and that its simplicity and low cost makes it well suited for sub-Saharan Africa.
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| INTRODUCTION
Cervical cancer is the fourth most common cancer in women worldwide (528 000 new cases), and the second most common cancer in developing countries (445 000 new cases) in 2012. 1 The disease burden is greatest among women from low-and middleincome countries (LMIC) and with limited medical service resources. 1, 2 In Sub-Saharan Africa, the age-standardized rate for cervical cancer is approximately 35 per 100 000 women. 1 Due to lack of cervical cancer screening services, African women are more likely to present with late-stage cancers, thus causing significant treatment expense to families and governments. 3 Human papillomavirus (HPV)
is one of the most common sexually transmitted infections (STIs) in the world. A majority of epidemiological studies have established that HPV is the primary cause of cervical cancer and genital warts. [4] [5] [6] genomes into the host genome; which finally leads to the progression toward high-grade dysplasia and cervical cancer. in a single reaction. 22 Our performance analysis showed that the HPV multiplex PCR genotyping assay is a reliable low-cost alternative to commercial methods.
| MATERIALS AND METHODS

| Study population and specimen collection
The study protocol was reviewed and approved by the Institutional | 309
| HPV hybridization method
PCR was performed using biotin-labeled MY09/MY11 consensus HPV L1 primers, in addition to biotin-labeled human β-globin primers, which were used as an indicator of DNA quality as previously described. otherwise the sample was considered negative.
| Statistical analyses
All statistical analyses were carried out using SAS software, version 9.4 (Cary, NC) and Excel 2016 (Microsoft, Seattle, WA). For purposes of the assay performance analyses, we chose a sample size of 104.
This initial sample size was based on resource practicality in the absence of reliable data on the expected performance of both assays. 
| RESULTS
The multiplex HPV PCR assay utilizes amplified products from 16 different HPV genotypes which map to different regions in the linear Figure   4B , are slightly smaller than those in the "per sample" graph ( Figure   4A ) due to an increased number of "events" counted. These results indicate that there is excellent agreement between the detection methods. The results of this comparison is summarized in Table 2 . In essence, these results suggest the HPV mPCR method has superior sensitivity. The analytical sensitivity and specificity of the multiplex HPV PCR assay were 100% and 94.26%, respectively. The clinical sensitivity is defined as the ability of the test to correctly identify those patients with disease, in this case the patients who had pap smear results of ASC-H to HSIL. While the clinical specificity refers to the ability of the test to correctly identify those patients without the disease (LSIL-NILM). 35 The clinical sensitivity and specificity of the multiplex HPV PCR and Line Blot hybridization using the Bethesda classification system 2001 were comparable. Table 3 T A B L E 1 Comparison of end-point detection limits obtained by real-time PCR, capillary electrophoresis, and gel electrophoresis Abbreviations: ALAS1, aminolevulinate synthase 1; HPV, human papilloma virus; PCR, polymerase chain reaction.
F I G U R E 3
The end-point detection limit of multiple HPV templates using the multiplex PCR assay. HPV genotypes: 6, 16, 31, 33, 52, and 56 were diluted by 10-fold serial dilution and subjected to multiplex PCR. The relative detection limit is indicated by the copy number per reaction above each lane (10 6 to 1 copies per reaction). HPV, human papilloma virus; Neg, negative control (without HPV DNA); Marker, 1-kb DNA marker; PCR, polymerase chain reaction classification, it is shown that the mPCR assay is more sensitive than the hybridization assay, since the HPV mPCR assay detected two more positive samples than the hybridization assay.
| DISCUSSION
The main goal of this study was to validate the analytical detection of and 100 copies per cell), which is crucial to studying the natural history of HPV pathogenesis and disease diagnosis. 26, 27 The downstream analyses using either PAGE or CE gives the researcher choices depending on resource availability, while still using the same simple PCR method.
Agreement between observers was 97.4% with a κ coefficient value of 0.946 (113 of 118 events), and 99% with κ coefficient equal to 0.978 (103 of 104 samples), with a McNemar score of P = 0.3173, signifying almost perfect agreement. As a matter of routine, we believe that it is more reliable to have two independent observers do genotype calls. Table 2 shows the results of all performance assays. The HPV mPCR assay offers high reliability for detection of HPV genotypes present in a single reaction, without exhaustion of PCR reagents (shown in Table 1 ).
This result shows that the assay can be reliable when simultaneous detection of multiple HPV genotypes is required. 28 Several studies suggest that infection of multiple HPV genotypes in the cervical epithelium is associated with development of cervical neoplasia. 29, 30 Like most of the HPV DNA amplification tests, mPCR showed high analytical sensitivity. Because of the extreme sensitivity of the assay, we prefer to premix reagents in PCR tubes under in a PCR clean room under an isolation hood. We clean all work surfaces, pipettes and gloves with 10% bleach before mixing reagents to avoid cross contamination. 
| 313
Comparing the HPV mPCR assay with the hybridization method demonstrates almost perfect agreement for the sixteen HPV genotypes tested (see Table 2 ). The selection of HR HPV genotypes From PCR reaction to genotype determination takes about 4 hours.
We found that the HPV multiplex PCR assay had the ability to detect HPV16 in African samples, despite the fact that there are known to be Africa-specific HPV16 variants from the region. 32 Some further optimization of this assay for African-specific variants may improve detection of HPV16 and perhaps other genotypes. Because of the sensitivity, this assay may also be useful to assess the role of HPV in
Adenocarcinomas. We did a small-scale analysis of the HPV multiplex assay for its ability to predict clinical disease determined by pap smear.
Clearly, a thorough clinical analysis would be needed with a much larger sample size to assess the clinical value of the assay. 33 High sensitivity and specificity in clinical samples would suggest that the assay has potential use particularly in low-resource clinical settings. Cervical cancer is highest in low income countries, thus, simple low-cost solutions to assess HPV related disease are essential. 1 The WHO has now suggested that HR HPV DNA testing should be prioritized over VIA. This will require wellvalidated and inexpensive HPV DNA detection assays. 34 The HPV multiplex assay described here would be a good candidate for clinical use in Sub-Saharan Africa. Abbreviations: ASCUS-HSIL, atypical squamous cells of higher pathological categories; NILM, negative for intraepithelial lesion or malignancy.
